Chabiotech Statistics

Total Valuation

Chabiotech has a market cap or net worth of KRW 577.65 billion. The enterprise value is 1.51 trillion.

Market Cap	577.65B
Enterprise Value	1.51T

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Chabiotech has 55.97 million shares outstanding. The number of shares has increased by 4.24% in one year.

Current Share Class	55.97M
Shares Outstanding	55.97M
Shares Change (YoY)	+4.24%
Shares Change (QoQ)	-1.33%
Owned by Insiders (%)	6.34%
Owned by Institutions (%)	12.10%
Float	46.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.55
PB Ratio	0.78
P/TBV Ratio	6.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-187.71
EV / Sales	1.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.63

Financial Position

The company has a current ratio of 0.73, with a Debt / Equity ratio of 1.11.

Current Ratio	0.73
Quick Ratio	0.64
Debt / Equity	1.11
Debt / EBITDA	n/a
Debt / FCF	-5.81
Interest Coverage	-1.61

Financial Efficiency

Return on equity (ROE) is -2.08% and return on invested capital (ROIC) is -2.80%.

Return on Equity (ROE)	-2.08%
Return on Assets (ROA)	-1.91%
Return on Invested Capital (ROIC)	-2.80%
Return on Capital Employed (ROCE)	-5.00%
Revenue Per Employee	3.58B
Profits Per Employee	-27.58M
Employee Count	292
Asset Turnover	0.53
Inventory Turnover	20.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.57% in the last 52 weeks. The beta is 0.41, so Chabiotech's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-38.57%
50-Day Moving Average	10,764.46
200-Day Moving Average	13,929.77
Relative Strength Index (RSI)	44.72
Average Volume (20 Days)	412,942

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Chabiotech had revenue of KRW 1.05 trillion and -8.05 billion in losses. Loss per share was -143.89.

Revenue	1.05T
Gross Profit	269.82B
Operating Income	-59.97B
Pretax Income	-6.20B
Net Income	-8.05B
EBITDA	-14.97B
EBIT	-59.97B
Loss Per Share	-143.89

Full Income Statement

Balance Sheet

The company has 353.50 billion in cash and 825.94 billion in debt, giving a net cash position of -472.44 billion or -8,440.35 per share.

Cash & Cash Equivalents	353.50B
Total Debt	825.94B
Net Cash	-472.44B
Net Cash Per Share	-8,440.35
Equity (Book Value)	745.15B
Book Value Per Share	5,063.22
Working Capital	-269.73B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -48.24 billion and capital expenditures -93.95 billion, giving a free cash flow of -142.19 billion.

Operating Cash Flow	-48.24B
Capital Expenditures	-93.95B
Free Cash Flow	-142.19B
FCF Per Share	-2,540.33

Full Cash Flow Statement

Margins

Gross margin is 25.82%, with operating and profit margins of -5.74% and -0.77%.

Gross Margin	25.82%
Operating Margin	-5.74%
Pretax Margin	-0.59%
Profit Margin	-0.77%
EBITDA Margin	-1.43%
EBIT Margin	-5.74%
FCF Margin	n/a

Dividends & Yields

Chabiotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.24%
Shareholder Yield	-4.24%
Earnings Yield	-1.39%
FCF Yield	-24.62%

Stock Splits

The last stock split was on June 2, 2014. It was a reverse split with a ratio of 0.7262.

Last Split Date	Jun 2, 2014
Split Type	Reverse
Split Ratio	0.7262

Scores

Chabiotech has an Altman Z-Score of 0.64. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.64
Piotroski F-Score	n/a